The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 31, 2021

Filed:

Dec. 13, 2019
Applicant:

Clyra Medical Technologies, Inc., Westminster, CA (US);

Inventors:

Spencer Brown, Westminster, CA (US);

Brock Liden, Westminster, CA (US);

Tanya Rhodes, Westminster, CA (US);

Joe Almasy, Westminster, CA (US);

Steven V. Harrison, Westminster, CA (US);

Douglas J. Morgan, Westminster, CA (US);

Assignee:

Clyra Medical Technologies, Inc., Westminster, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 13/00 (2006.01); A61B 1/015 (2006.01); A61B 1/317 (2006.01); A61B 1/018 (2006.01); A61B 1/04 (2006.01); A61M 3/02 (2006.01); A61B 90/00 (2016.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61M 13/00 (2013.01); A61B 1/015 (2013.01); A61B 1/018 (2013.01); A61B 1/04 (2013.01); A61B 1/317 (2013.01); A61M 3/0283 (2013.01); A61M 13/006 (2014.02); A61B 2017/0034 (2013.01); A61B 2090/3912 (2016.02); A61B 2090/3933 (2016.02); A61B 2090/3941 (2016.02); A61M 2205/0205 (2013.01);
Abstract

Systems and methods for reducing pathogens near an implant are discussed. In some cases, the methods include reducing contaminants in a portion of a patient that has an implant and that is disposed interior to a closed surface of skin of the patient. The method can further include placing a conduit in the closed surface of skin and flowing an antimicrobial fluid into that portion of the patient to contact the antimicrobial fluid with a surface of the implant and tissue adjacent to the implant. In some cases, the antimicrobial fluid is then removed from the portion of the patient having the implant. As part of this method, biofilm near the implant can be mechanically, ultrasonically, electrically, chemically, enzymatically, or otherwise disrupted. Other implementations are described.


Find Patent Forward Citations

Loading…